Vasiliki Triantafyllia

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Tom Le Voyer et al. · Science Immunology · 2021 · 600 citations · Full text

Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison

Ioanna E. Galani, Vicky Lampropoulou, Vasiliki Triantafyllia et al. · Nature Immunology · 2020 · 513 citations · Full text

Viral Persistence, Antiviral Immunity, Covid-19 Pandemic +8

Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness

Ioanna E. Galani, Vasiliki Triantafyllia, Evridiki-Evangelia Eleminiadou et al. · Immunity · 2017 · 479 citations · Full text

Cross-protection, Immunology, Antiviral Drug Development +9

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 180 citations · Full text

Ifn Autoantibodies, Immunology, Age Dependent +16

Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries

Abdul Rouf Banday, Megan L. Stanifer, Oscar Flórez-Vargas et al. · Nature Genetics · 2022 · 132 citations · Full text